이해승(HaeSeung Lee)  사진
이해승(HaeSeung Lee)
직책
조교수
전화번호
+82-51-510-2823
이메일
haeseung@pusan.ac.kr
홈페이지
전공
생물정보학, 시스템생물학
연구실
약학관 1011호

학력 Education  

2005. 03 - 2009. 08     이화여자대학교 생명과학과 (학사)
2009. 09 - 2015. 08     이화여자대학교 생명약학부 (석·박통합)

 

경력 Experience    

2015. 08 - 2017. 05     이화여자대학교 (박사후 연구원)
2017. 06 - 2020. 03     이화여자대학교 (연구교수)
2020. 03 - 2021. 08     한국한의학연구원 (연구원)
2021. 09 - 현재             부산대학교 약학대학 (조교수)

 

연구업적 Achievements 

(*: equal contribution, : Corresponding author)

1. Choi JY*, Lee H*, Kwon EJ*, Kong HJ, Kwon OS, Cha HJ, TGF-β promotes YAP dependent AXL induction in mesenchymal lung cancer cells, Molecular Oncology, 15(2):679-696 (2021)

 

2. Kong HJ, Kwon EJ, Kwon OS, Lee H, Choi JY, Kim YJ, Kim W, Cha HJ, Crosstalk between YAP and TGF-β regulates SERPINE1 expression in mesenchymal lung cancer cells. International Journal of Oncology, 58(1):111-121 (2021)

 

3. Kwon OS, Kwon EJ, Kong HJ, Choi JY, Kim YJ, Lee EW, Kim W, Lee H, Cha HJ, Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis. Redox Biology, 37:101719 (2020)

 

4. Kwon OS*, Lee H*, Kong HJ, Park JE, Lee W, Kang S, Kim M, Kim W, Cha HJ, Connectivity Map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene, 39(23):4567-4580 (2020)

 

5. Jeon J*, Noh HJ*, Lee H, Park HH, Park SH, Lee H, Kim SJ, Kang HC, Eyun SI, Yang S, Kim YS, TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis. Annals of the Rheumatic Diseases, 79(12):1635-1643 (2020)

 

6. Park DR, Kim JH, Kim KM, Lee H, Kim M, Hwang D, Lee H, Kim HS, Kim W, Park MC, Shim H, Choi Y, Lee SY, Osteoclast-associated receptor blockade prevents articular cartilage destruction via chondrocyte apoptosis regulation. Nature Communications, 11(1):4343 (2020)

 

7. Kim KT*, Park JC*, Lee H, Jang HK, Jin Y, Kim W, Lee J, Kim H, Bae S, Cha HJ, Safe Scarless Cassette-free Selection of Genome-edited Human Pluripotent Stem Cells Using Temporary Drug Resistance. Biomaterials, 262:120295 (2020)

 

8. Jeong M, Seong D, Seo J, Shin JY, Lee SY, Nam YW, Jo JY, Lee H, , Oberst A, Vandenabeele P, Shin DH, Lee EW, Song J, Identification of MYC as an anti-necroptotic protein that stifles RIPK1-RIPK3 complex formation. Proceedings of the National Academy of Sciences, 117(33):19982-19993 (2020)

 

9. Kwon OS, Lee H, Kim YJ, Cha HJ, Song NY, Lee MO, ERK Dephosphorylation through MKP1 Deacetylation by SIRT1 Attenuates RAS-Driven Tumorigenesis. Cancers, 12(4):909 (2020)

 

10. Kwon OS, Kim W, Cha HJ, Lee H, In silico drug repositioning: from large-scale transcriptome data to therapeutics. Archives of Pharmacal Research, 42(10):879-889 (2019)

 

11. Go YH*, Lim C*, Jeong HC*, Kwon OS, Chung S, Lee H, .., Lee MO, Cha HJ, Kim SH, Structure-activity relationship analysis of YM155 for inducing selective cell death of human pluripotent stem cells. Frontiers in Chemistry, 7:298 (2019)

 

12. Park S, Kwon Y, Jung H, Jang S, Lee H, Kim W, CSgator: an integrated web platform for compound set analysis. Journal of Cheminformatics, 11(1):17 (2019)

 

13. Hong SK*, Lee H*, Kwon OS*, , Kim W, Cha HJ, Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer, Molecular Cancer. 17(1):175 (2018)

 

14. Lee H, Kang S, Kim W, Drug Repositioning for cancer therapy based on large-scale drug-induced transcriptional signature. PLoS ONE, 11(3):e0150460, (2016)


15. Yoo HY*, Sung MK*, Lee SH, Kim S, Lee H, , Lee S, Ko YH, A recurrent inactivating mutation in RHOA GTPase in angioimmuno-blastic T cell lymphoma. Nature Genetics, 46(4):371-5 (2014)

 

16. Kim P, Yoon S, Kim N, Lee S, Ko M, Lee H, Kang H, Kim J, Lee S, ChimerDB 2.0-a knowledgebase for fusion genes updated. Nucleic Acids Research, 38(Database issue):D81-5 (2010)